New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
FSD Pharma Inc.
HUGE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

66671

Drug Manufacturers - Specialty & Generic

Next Earning date - 26 Mar 2025

66671

Drug Manufacturers - Specialty & Generic

Next Earning date - 26 Mar 2025

0.09USD

Shape-0.01 ( -10.10%)
sun-fogPre-market 0.00$arrow-left-down-0.09 (-100.00%)
Market Closed (as of Aug 14, 20:00 EDT)
favorite-chart

Relative Strenght

1
favorite-chart

Volume Buzz

11123%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated February 6, 2025
1W % 1M % 3M % 1Y -92.96 %

Key Metrics

Shape
  • Market Cap

    66671


  • Shares Outstanding

    741612


  • Share in Float

    600696


  • Dividende

    0


  • Earning Date

    26 Mar 2025


  • Price Target

    0.0899


  • Average Volume

    196163


  • Beta

    0.848


  • Range

    0.087-109.1935


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.fsdpharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

HUGE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$9M

ShapeNaN%

2025-Revenue

$0.17

Shape-261%

2025-EPS

$5M

Shape345%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.21
vs -0.35

Q3.22

arrow
arrow

N/A

-0.19
vs -0.15

Q4.22

arrow
arrow

N/A

-0.16
vs -0.14

Q1.23

arrow
arrow

N/A

-0.26
vs -0.14

Q2.23

arrow
arrow

N/A

-0.14
vs -0.21

Q3.23

arrow
arrow

N/A

-0.03
vs -0.19

Q4.23

arrow
arrow

N/A

-0.04
vs -0.16

Q1.24

arrow
arrow

N/A

-0.05
vs -0.26

Q2.24

arrow
arrow

N/A

-0.08
vs -0.14

Q3.24

arrow
arrow

N/A

-0.08
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

707K  vs NA

Q3.24

arrow
arrow

NA

707K  vs NA

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-11%

-0.11
vs -0.12

Q3.22

arrow
arrow

-20%

-0.20
vs -0.11

Q4.22

arrow
arrow

-19%

-0.19
vs -0.20

Q1.23

arrow
arrow

-52%

-0.52
vs -0.19

Q2.23

arrow
arrow

-54%

-0.54
vs -0.52

Q3.23

arrow
arrow

-8%

-0.08
vs -0.54

Q4.23

arrow
arrow

-13%

-0.13
vs -0.08

Q1.24

arrow
arrow

-16%

-0.16
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

23

23
vs 27

-15%

Q2.22

arrow
arrow

18

18
vs 23

-22%

Q3.22

arrow
arrow

16

16
vs 18

-11%

Q4.22

arrow
arrow

18

18
vs 16

13%

Q1.23

arrow
arrow

17

17
vs 18

-6%

Q2.23

arrow
arrow

13

13
vs 17

-24%

Q3.23

arrow
arrow

18

18
vs 13

38%

Q4.23

arrow
arrow

1

1
vs 18

-94%

Earnings Growth

Latest News